BioSpace News Archive

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that it will participate in a fireside chat during the SVB Securities Virtual Vaccine Forum.

Illumina, Inc. announced its financial results for the second quarter of fiscal year 2022, which include consolidated financial results for GRAIL.

BIOLASE, Inc., the global leader in dental lasers, announced its financial results for the second quarter ended June 30, 2022.

Poseida Therapeutics, Inc. announced business updates and financial results for the second quarter ended June 30, 2022.

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its second quarter 2022 and provided a corporate update.

Azenta, Inc. announced that Company management will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.

Trevi Therapeutics, Inc. (Nasdaq: TRVI), today announced financial results for the quarter ended June 30, 2022, as well as provided business updates.

NewAmsterdam Pharma announced the publication of full results from the Phase 2b Randomized Study of Obicetrapib as an Adjunct to Statin Therapy clinical trial in the peer-reviewed journal, Nature Medicine.

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today reported financial results for the quarter ended June 30, 2022.

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today reported financial results for the second quarter ended June 30, 2022 and provided a business update.